- Exchange: ISDX
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
GW Pharmaceuticals PLC
+ Add to WatchlistGWP:PZ
49.00 GBp 0.000.00%As of 11:30:00 ET on 05/21/2013.
Snapshot for GW Pharmaceuticals PLC (GWP)
| Open: | 49.00 | Day's Range: | 48.50 - 49.00 | Volume: | 19,215 |
|---|---|---|---|---|---|
| Previous Close: | 49.00 | 52wk Range: | 41.50 - 78.50 | 1-Yr Rtn: | - |
Key Statistics for GWP
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(09/2013) | - |
| Relative P/E vs. UKX | - |
| Earnings Per Share (GBP) (ttm) | - |
| Est. EPS (GBP) (09/2013) | -0.0460 |
| Est. PEG Ratio | - |
| Market Cap (M GBP) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 85,014 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 06/03/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for GWP
Company Profile & Key Executives for GWP
GW Pharmaceuticals plc researches and develops cannabinoid prescription medicines for the treatment of cancer pain, Multiple Sclerosis, and neuropathic pain.
| Geoffrey William GuyChairman/Founder | Justin David GoverChief Executive Officer |
| Adam David GeorgeCFO/Secretary | Christopher John Tovey "Chris"Chief Operating Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
GWP News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page